Dec 03, 2025
1:10
For every 10 shares held, investors received 1.
The split itself did not change the total investment value.
Sutro Biopharma, Inc. (GETTEX:S090) operates in the Pharmaceuticals: major industry.
Sutro Biopharma, Inc. company overviewSutro Biopharma, Inc.'s most recent stock split was on December 3, 2025. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Sutro Biopharma, Inc. has split its stock once. This history records one reverse split, on December 3, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Sutro Biopharma, Inc.'s 1-for-10 reverse split on December 3, 2025, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Sutro Biopharma, Inc. has not announced a new split in our records. Its most recent split was on December 3, 2025, less than a year ago. Companies announce splits in advance, and any new GETTEX:S090 split will appear on this page.